Clinical Trial Update: Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for avasopasem in metastatic hormone receptor-positive breast cancer with progression on a CDK4/6 inhibitor and hormonal therapy; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer Metastatic

Drugs mentioned

• Avasopasem (avasopasem)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Breast Cancer Metastatic | Phase 1 | Status: RECRUITING